About Alvogen
Alvogen is a global, privately held pharmaceutical company that develops, manufactures and markets generic, branded, over-the-counter (OTC) and biosimilars for patients worldwide. With 2,800 employees in 35 countries, the company has business operations worldwide and five manufacturing and development centers in the United States, Romania, South Korea and Taiwan. Alvogen leadership team is committed to creating a dynamic, change-oriented culture that is focused on meeting customer needs. Their streamlined and flexible structure enables rapid and efficient decision making, enabling the company to bring new generic products to market quickly and safely. Its business areas include: product development, contract manufacturing and research (CMO), as well as generic (Gx and Hx), biosimilars and OTC sales. In addition to its rapidly growing portfolio of biosimilars and over-the-counter products, its portfolio includes leading molecules for the treatment of oncology, cardiology, respiratory, neurology, and gastroenterology.